2008
DOI: 10.1016/s1098-3015(10)70907-4
|View full text |Cite
|
Sign up to set email alerts
|

Pss12 Cost-Effectiveness Analysis of Bevacizumab and Ranibizumab in Neovascularage-Related Macular Degeneration (Amd): A Clinical and Economic Comparison of Two Vascular Endothelial Growth Factor Inhibitor Treatments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance